Business Wire (Free subscription) | 09/30/2008
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB) today announced it will report third quarter 2008 financial results on Tuesday, October 21, 2008, before the financial
Business Wire (Free subscription) | 09/23/2008
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ/BIIB) announced today that its presentation at the UBS Global Life Sciences Conference in New York, NY will be webcast live via
Market Wire - Financial Services: Venture Capital (Free subscription) | 09/03/2008
ACADIA Pharmaceuticals Inc. Affymax, Inc. Affymetrix, Inc. Agilent Technologies, Inc. Alkermes, Inc. Allscripts Healthcare Solutions, Inc. American Medical Systems, Inc. AmerisourceBergen Corporation AMICAS, Inc. Amylin Pharmaceuticals, Inc. Archus Orthopedics, Inc. Array BioPharma Inc. Asuragen, Inc. athenahealth,...
Market Wire - Financial Services: Investment Services and Trading (Free subscription) | 09/03/2008
ACADIA Pharmaceuticals Inc. Affymax, Inc. Affymetrix, Inc. Agilent Technologies, Inc. Alkermes, Inc. Allscripts Healthcare Solutions, Inc. American Medical Systems, Inc. AmerisourceBergen Corporation AMICAS, Inc. Amylin Pharmaceuticals, Inc. Archus Orthopedics, Inc. Array BioPharma Inc. Asuragen, Inc. athenahealth,...
Business Wire (Free subscription) | 09/04/2008
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ/BIIB) announced today that its presentation at the CITI Biotech Day will be webcast live via the internet, on Monday, September 8,
PR News Wire (Free subscription) | 09/22/2008
... General Electric Co. (NYSE: ), United States Steel Corp. (NYSE: ), Newmont Mining Corp. (NYSE: ), Biogen Idec Inc. (Nasdaq: ), and Bunge Ltd. (NYSE: ). Along with our PriceWatch Alerts, these brief reports contain a concise market overview, economic calendar and current news leaders and laggards. PriceWatch Alerts include hedged trade ideas designed to potentially protect investors...
Market Wire (Free subscription) | 09/16/2008
... as of 6/30/2008 PowerShares Global Biotech Portfolio (PBTQ) Company Index Weight (%) Amgen Inc. 8.00 Gilead Sciences Inc. 8.00 GenenTech 8.00 Celgene Corp. 8.00 Genzyme Corp. 8.00 CSL Ltd. 4.00 Biogen Idec Inc. 4.00 Actelion Ltd. 4.00 Vertex Pharmaceuticals Inc. 4.00 Cephalon Inc. 3.87 Source: The NASDAQ OMX Group, Inc., based on hypothetical Index...
Business Wire (Free subscription) | 09/03/2008
CAMBRIDGE, Mass. $ CARLSBAD, Calif.--(BUSINESS WIRE)--Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Isis Pharmaceuticals, Inc. (Nasdaq:
Market Wire - Professional Services: Investor Relations (Free subscription) | 09/03/2008
... PowerShares Global Biotech Portfolio (PBTQ) Index Company Weight(%) ------- -------- Amgen Inc. 8.00 Gilead Sciences Inc. 8.00 GenenTech 8.00 Celgene Corp. 8.00 Genzyme Corp. 8.00 CSL Ltd. 4.00 Biogen Idec Inc. 4.00 Actelion Ltd. 4.00 Vertex Pharmaceuticals Inc. 4.00 Cephalon Inc. 3.87 Source: The NASDAQ OMX Group, Inc., based on hypothetical Index...
Raw Story (Free subscription) | 09/06/2008
... and it has also been linked to a rare kind of brain infection that is often fatal. Manufacturer Biogen Idec Inc. said it does not believe there is an increased risk of melanoma.The FDA said drugs will be placed on the list based on reports it receives from hospitals, doctors and patients."What's new here is that we are telling the public really at the earliest stage what we are working...
Orlando Sentinel (Free subscription) | 09/06/2008
... and it has also been linked to a rare kind of brain infection that is often fatal. Manufacturer Biogen Idec Inc. said it does not believe there is an increased risk of melanoma.The FDA said drugs will be placed on the list based on reports it receives from hospitals, doctors and patients."What's new here is that we are telling the public really at the earliest stage what we are working...
Seattle Post-Intelligencer (Free subscription) | 09/06/2008
... and it has also been linked to a rare kind of brain infection that is often fatal. Manufacturer Biogen Idec Inc. said it does not believe there is an increased risk of melanoma.The FDA said drugs will be placed on the list based on reports it receives from hospitals, doctors and patients."What's new here is that we are telling the public really at the earliest stage what we are working...
kansascity.com (Free subscription) | 09/06/2008
... and it has also been linked to a rare kind of brain infection that is often fatal. Manufacturer Biogen Idec Inc. said it does not believe there is an increased risk of melanoma.
The FDA said drugs will be placed on the list based on reports it receives from hospitals, doctors and patients.
"What's new here is that we are telling the public really at the earliest stage...
The Earth Times Online Newspaper (Free subscription) | 08/26/2008
... Summits Strategic Investments NewsBites cover the following stocks: Potash Corp. of Saskatchewan, Inc. (NYSE: POT), Marvell Technology Group Ltd. (Nasdaq: MRVL), EOG Resources, Inc. (NYSE: EOG), Biogen Idec Inc. (Nasdaq: BIIB), and Yum! Brands Inc. (NYSE: YUM). These brief stock reports may contain details regarding recent or anticipated stock moves, resistance...
PR News Wire (Free subscription) | 08/26/2008
CHICAGO, Aug. 26 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks. Seven Summits Strategic Investments NewsBites are available to all investors at: (Note: You may have to copy this link into your browser then press the [ENTER] key.) Today's Seven Summits Strategic Investments NewsBites cover the following stocks: Potash Corp. of Saskatchewan, Inc. (NYSE: ), Marvell Technology...
